Examining the Link Between Glucagon-Like Peptide-1 Receptor Agonists and Neovascular Age-Related Macular Degeneration Risk
A recent cohort study published in JAMA Ophthalmology has unveiled a potentially alarming association between the use of glucagon-like peptide-1 ...
